Legend Biotech (LEGN) Return on Capital Employed (2020 - 2025)
Historic Return on Capital Employed for Legend Biotech (LEGN) over the last 6 years, with Q3 2025 value amounting to 108.99%.
- Legend Biotech's Return on Capital Employed rose 780900.0% to 108.99% in Q3 2025 from the same period last year, while for Sep 2025 it was 108.99%, marking a year-over-year increase of 780900.0%. This contributed to the annual value of 99.11% for FY2024, which is 307600.0% down from last year.
- Per Legend Biotech's latest filing, its Return on Capital Employed stood at 108.99% for Q3 2025, which was up 780900.0% from 99.58% recorded in Q2 2025.
- In the past 5 years, Legend Biotech's Return on Capital Employed ranged from a high of 108.99% in Q3 2025 and a low of 17.81% during Q4 2021
- Over the past 5 years, Legend Biotech's median Return on Capital Employed value was 14.45% (recorded in 2022), while the average stood at 31.71%.
- Its Return on Capital Employed has fluctuated over the past 5 years, first crashed by -178100bps in 2021, then soared by 780900bps in 2025.
- Quarter analysis of 5 years shows Legend Biotech's Return on Capital Employed stood at 17.81% in 2021, then surged by 103bps to 0.46% in 2022, then skyrocketed by 6138bps to 28.44% in 2023, then skyrocketed by 241bps to 96.84% in 2024, then increased by 13bps to 108.99% in 2025.
- Its Return on Capital Employed was 108.99% in Q3 2025, compared to 99.58% in Q2 2025 and 98.06% in Q1 2025.